Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens!
作者信息
Tsirigotis Panagiotis, Spyridonidis Alexandros, Gkirkas Konstantinos, Chondropoulos Spiros, Rondogianni Phivi, Thomopoulos Thomas, Karagiannidou Angeliki, Vythoulkas Dionysios, Griniezaki Marianna, Georgakopoulos Nikolaos, Stamouli Maria, Foukas Periklis G
机构信息
Second Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece.
Department of Bone Marrow Transplantation, University Hospital of Rio Patras, Medical School, University of Patras, Greece.
出版信息
Blood Transfus. 2023 Sep;21(5):437-440. doi: 10.2450/BloodTransfus.498. Epub 2023 Mar 10.
Abstract
摘要
相似文献
1
Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens!异基因造血干细胞移植后供体向受体的实体瘤转移：虽罕见但确有发生！
Blood Transfus. 2023 Sep;21(5):437-440. doi: 10.2450/BloodTransfus.498. Epub 2023 Mar 10.
2
Recipient and donor cells in the graft-versus-solid tumor effect: It takes two to tango.移植物抗实体瘤效应中的受者和供者细胞：这需要双方共同努力。
Blood Rev. 2018 Nov;32(6):449-456. doi: 10.1016/j.blre.2018.04.002. Epub 2018 Apr 12.
3
Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后受体型内皮细胞的持续存在。
Haematologica. 2011 Jan;96(1):119-27. doi: 10.3324/haematol.2010.030288. Epub 2010 Oct 7.
4
CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.CD4+CD25+ 调节性 T 细胞耗竭可增强异基因造血干细胞移植后供者淋巴细胞的移植物抗肿瘤效应。
Sci Transl Med. 2010 Jul 21;2(41):41ra52. doi: 10.1126/scitranslmed.3001302.
5
[Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].[美国实体瘤的异基因造血干细胞移植：综述]
Nihon Rinsho. 2003 Sep;61(9):1619-34.
6
Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.供受者Rh血型不匹配对异基因造血干细胞移植后结局无影响。
Transfusion. 2008 Jan;48(1):163-8. doi: 10.1111/j.1537-2995.2007.01501.x. Epub 2007 Sep 27.
7
Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation.供受者ABO血型不匹配对异基因造血干细胞移植后结局无影响。
Bone Marrow Transplant. 2006 Nov;38(9):615-20. doi: 10.1038/sj.bmt.1705496. Epub 2006 Sep 11.
8
Immunobiology of allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植的免疫生物学
Annu Rev Immunol. 2007;25:139-70. doi: 10.1146/annurev.immunol.25.022106.141606.
9
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
10
Targets of tumor immunity after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后的肿瘤免疫靶点。
Clin Cancer Res. 2008 Aug 15;14(16):4997-9. doi: 10.1158/1078-0432.CCR-08-0857.
本文引用的文献
1
Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis.
Leuk Lymphoma. 2022 Feb;63(2):499-502. doi: 10.1080/10428194.2021.1984456. Epub 2021 Oct 25.
2
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation.欧洲造血细胞移植后供体细胞衍生白血病/骨髓增生异常综合征的经验和危险因素分析。
Leukemia. 2019 Feb;33(2):508-517. doi: 10.1038/s41375-018-0218-6. Epub 2018 Jul 26.
3
Horizontal DNA transfer from donor to host cells as an alternative mechanism of epithelial chimerism after allogeneic hematopoietic cell transplantation.同种异体造血细胞移植后上皮嵌合体形成的另一种机制：供体细胞向宿主细胞的水平 DNA 转移。
Biol Blood Marrow Transplant. 2011 Mar;17(3):319-29. doi: 10.1016/j.bbmt.2010.09.001. Epub 2010 Sep 15.
4
Donor-derived solid malignancies after hematopoietic stem cell transplantation.造血干细胞移植后供者来源的实体恶性肿瘤
Onkologie. 2010;33(4):195-200. doi: 10.1159/000290661. Epub 2010 Mar 19.
5
Quantitative monitoring of multi-donor chimerism: a systematic, validated framework for routine analysis.定量监测多供者嵌合体：一种系统的、经过验证的常规分析框架。
Bone Marrow Transplant. 2010 Jan;45(1):137-47. doi: 10.1038/bmt.2009.120. Epub 2009 Jun 8.
6
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation.人类胃肠道肿瘤相关肌成纤维细胞可在同种异体干细胞移植后由骨髓来源的细胞发育而来。
Stem Cells. 2009 Jun;27(6):1463-8. doi: 10.1002/stem.63.
7
Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation.异基因骨髓移植后供者来源的口腔鳞状细胞癌
Blood. 2009 Feb 19;113(8):1834-40. doi: 10.1182/blood-2008-07-171702. Epub 2008 Dec 5.
8
Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis.肿瘤细胞与骨髓来源细胞的融合：转移的统一解释
Nat Rev Cancer. 2008 May;8(5):377-86. doi: 10.1038/nrc2371.
9
Gastric cancer originating from bone marrow-derived cells.源自骨髓源性细胞的胃癌。
Science. 2004 Nov 26;306(5701):1568-71. doi: 10.1126/science.1099513.
10
Epithelial tissue chimerism after human hematopoietic cell transplantation is a real phenomenon.人类造血细胞移植后的上皮组织嵌合是一种真实存在的现象。
Am J Pathol. 2004 Apr;164(4):1147-55. doi: 10.1016/S0002-9440(10)63203-8.
Zotero 插件